STERIS’ (TSE:STE – Free Report) – Analysts at Atb Cap Markets lifted their Q2 2025 earnings per share estimates for STERIS’ in a research note issued on Thursday, May 15th. Atb Cap Markets analyst W. Syed now expects that the company will post earnings per share of $0.12 for the quarter, up from their prior estimate of $0.09. Atb Cap Markets also issued estimates for STERIS’’s Q3 2025 earnings at $0.28 EPS and FY2025 earnings at $0.69 EPS.
Separately, Raymond James downgraded STERIS’ from a “moderate buy” rating to a “hold” rating in a report on Wednesday, April 9th.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Recommended Stories
- Five stocks we like better than STERIS’
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- What is a SEC Filing?
- Savvy Investors Are Raising a Glass for Heineken Stock
- Bank Stocks – Best Bank Stocks to Invest In
- Top 4 ETFs for China Exposure After Tariff Relief
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
